Bleeker WK - Search Results

1

Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase.

Bleeker WK, Teeling JL, Verhoeven AJ, Rigter GM, Agterberg J, Tool AT, Koenderman AH, Kuijpers TW, Hack CE. Bleeker WK, et al. Blood. 2000 Mar 1;95(5):1856-61. Blood. 2000. PMID: 10688848 Free article.

2

Human intravenous immunoglobulin (IVIG) preparations degranulate human neutrophils in vitro.

Teeling JL, De Groot ER, Eerenberg AJ, Bleeker WK, Van Mierlo G, Aarden LA, Hack CE. Teeling JL, et al. Among authors: bleeker wk. Clin Exp Immunol. 1998 Nov;114(2):264-70. doi: 10.1046/j.1365-2249.1998.00697.x. Clin Exp Immunol. 1998. PMID: 9822286 Free PMC article.

3

Intravenous immunoglobulin preparations induce mild activation of neutrophils in vivo via triggering of macrophages--studies in a rat model.

Teeling JL, Bleeker WK, Rigter GM, van Rooijen N, Kuijpers TW, Hack CE. Teeling JL, et al. Among authors: bleeker wk. Br J Haematol. 2001 Mar;112(4):1031-40. doi: 10.1046/j.1365-2141.2001.02674.x. Br J Haematol. 2001. PMID: 11298603 Free article.

4

Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia.

Teeling JL, Jansen-Hendriks T, Kuijpers TW, de Haas M, van de Winkel JG, Hack CE, Bleeker WK. Teeling JL, et al. Among authors: bleeker wk. Blood. 2001 Aug 15;98(4):1095-9. doi: 10.1182/blood.v98.4.1095. Blood. 2001. PMID: 11493456 Free article.

5

Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect.

Bleeker WK, Teeling JL, Hack CE. Bleeker WK, et al. Blood. 2001 Nov 15;98(10):3136-42. doi: 10.1182/blood.v98.10.3136. Blood. 2001. PMID: 11698302 Free article.

6

Key role of macrophages in hypotensive side effects of immunoglobulin preparations. Studies in an animal model.

Bleeker WK, Agterberg J, Rigter G, van Rooijen N, Bakker JC. Bleeker WK, et al. Clin Exp Immunol. 1989 Sep;77(3):338-44. Clin Exp Immunol. 1989. PMID: 2805404 Free PMC article.

7

Evaluation of the immunogenicity of polymerized hemoglobin solutions in a rabbit model.

Bleeker WK, Zappeij LM, den Boer PJ, Agterberg JA, Rigter GM, Bakker JC. Bleeker WK, et al. Artif Cells Blood Substit Immobil Biotechnol. 1995;23(4):461-8. doi: 10.3109/10731199509117962. Artif Cells Blood Substit Immobil Biotechnol. 1995. PMID: 7581832

8

Prevention of side effects by hemoglobin solutions; the selection of optimal test models, especially concerning thrombogenicity.

Bakker JC, Bleeker WK, Den Boer PJ, Biessels PT, Agterberg J, Rigter G, Holthuis JC, Mertens K. Bakker JC, et al. Among authors: bleeker wk. Artif Cells Blood Substit Immobil Biotechnol. 1994;22(3):577-85. doi: 10.3109/10731199409117886. Artif Cells Blood Substit Immobil Biotechnol. 1994. PMID: 7994377

9

Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats.

de Smet BJ, de Boer JP, Agterberg J, Rigter G, Bleeker WK, Hack CE. de Smet BJ, et al. Among authors: bleeker wk. Blood. 1993 Jan 1;81(1):56-61. Blood. 1993. PMID: 8417802 Free article.

10

Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia.

Minnema MC, Pajkrt D, Wuillemin WA, Roem D, Bleeker WK, Levi M, van Deventer SJ, Hack CE, ten Cate H. Minnema MC, et al. Among authors: bleeker wk. Blood. 1998 Nov 1;92(9):3294-301. Blood. 1998. PMID: 9787166 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters